NCT06001372 2025-04-16
TREK
University of Utah
Phase EARLY_PHASE1 Terminated
Clinical Trials
9 trialsNCT03153410 2025-01-09
Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients With Borderline Resectable Adenocarcinoma of the Pancreas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase EARLY_PHASE1 Completed
NCT03519308 2024-03-15
A Pilot Study of Perioperative Nivolumab and Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer
Abramson Cancer Center at Penn Medicine
Phase EARLY_PHASE1 Terminated
NCT01434342 2021-09-28
Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients
Wake Forest University Health Sciences
Phase EARLY_PHASE1 Completed
NCT03291379 2021-07-19
VEROnA
Boston Scientific Corporation
Phase EARLY_PHASE1 Completed
NCT03515941 2020-10-12
GABLE
Baylor College of Medicine
Phase EARLY_PHASE1 Terminated
NCT01247298 2017-08-21
RAD 0902
University of Alabama at Birmingham
Phase EARLY_PHASE1 Completed
NCT01673802 2017-06-01
The Role of Gadoxetate (Eovist) Enhanced CT in Evaluating Cholangiocarcinoma
University of Alabama at Birmingham
Phase EARLY_PHASE1 Completed
NCT00835679 2014-05-23
Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery
National Cancer Institute (NCI)
Phase EARLY_PHASE1 Terminated